4.8 Review

Beneficial Immune Regulation by Biological Response Modifier Glucans in COVID-19 and Their Envisaged Potentials in the Management of Sepsis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

In silico study of potential immunonutrient-based sports supplements against COVID-19 via targeting ACE2 inhibition using molecular docking and molecular dynamics simulations

Ebrahim Banitalebi et al.

Summary: The use of certain sports supplements can inhibit ACE2, a receptor for the SARS-CoV-2 virus, thereby enhancing immune responses in athletes. This study highlights the potential of immunonutrient-based sports supplements as preventive and therapeutic options for COVID-19 in the absence of an effective vaccine.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2023)

Article Medicine, Research & Experimental

Beneficial effects of novel aureobasidium pullulans strains produced beta-1,3-1,6 glucans on interleukin-6 and D-dimer levels in COVID-19 patients; results of a randomized multiple-arm pilot clinical study

Kadalraja Raghavan et al.

Summary: This pilot clinical study demonstrated the beneficial effects of beta glucans derived from black yeast Aureobasidium pullulans on cytokine storm and coagulopathy biomarkers in COVID-19 patients. The combination of AFO-202 and N-163 beta glucans showed significant improvements in D-Dimer and IL-6 levels, as well as CD4+ and CD8+ T cell count. Larger multicentric clinical studies are recommended to further validate these findings for potential use in managing COVID-19 and long COVID-19 syndrome.

BIOMEDICINE & PHARMACOTHERAPY (2022)

Article Chemistry, Applied

Comparison of structural differences between yeast -glucan sourced from different strains of saccharomyces cerevisiae and processed using proprietary manufacturing processes

Jean A. Boutros et al.

Summary: The study found that each proprietary source of yeast 8-glucan has a unique purity profile, branching, and linkage patterns that determine the chemical structure and composition.

FOOD CHEMISTRY (2022)

Article Critical Care Medicine

Intravenous immunoglobulins in patients with COVID-19-associated moderate-to-severe acute respiratory distress syndrome (ICAR): multicentre, double-blind, placebo- controlled, phase atrial

Aurelien Mazeraud et al.

Summary: In patients with moderate-to-severe ARDS caused by COVID-19 and receiving invasive mechanical ventilation, IVIG did not improve clinical outcomes at day 28 and may be associated with an increased frequency of serious adverse events. The effect of IVIGs on earlier stages of COVID-19 should be assessed in future trials.

LANCET RESPIRATORY MEDICINE (2022)

Letter Respiratory System

The Value of C-Reactive Protein-to-Lymphocyte Ratio in Predicting the Severity of SARS-CoV-2 Pneumonia

Catia Cilloniz et al.

ARCHIVOS DE BRONCONEUMOLOGIA (2021)

Article Virology

Defining IL-6 levels in healthy individuals: A meta-analysis

Elias A. Said et al.

Summary: This meta-analysis is the first to report IL-6 levels in the blood of healthy donors based on a large number of studies, with a pooled estimate of 5.186 pg/ml. Results showed that IL-6 values increased by 0.05 pg/ml for every 1 year increase in age. Despite heterogeneity, differences in IL-6 values were within a few pg/ml range, possibly due to varying conditions impacting IL-6 production in the healthy population.

JOURNAL OF MEDICAL VIROLOGY (2021)

Article Biochemistry & Molecular Biology

Anti-inflammatory effects of β-1,3-1,6-glucan derived from black yeast Aureobasidium pullulans in RAW264.7 cells

Huiwon No et al.

Summary: The low-molecular-weight A. pullulans-fermented beta-D-glucan showed potential as an immune modulator by reducing the release of inflammatory mediators and modulating key signaling pathways in LPS-stimulated macrophages.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2021)

Review Nutrition & Dietetics

Biological Activity of High-Purity β-1,3-1,6-Glucan Derived from the Black Yeast Aureobasidium pullulans: A Literature Review

Toshio Suzuki et al.

Summary: The black yeast Aureobasidium pullulans produces abundant soluble beta-1,3-1,6-glucan, which is a functional food ingredient with various health benefits. Studies have shown its immunomodulatory, antitumor, antiallergic effects, as well as its potential in reducing lifestyle-related disease risks. β-Glucan is a promising material for both food and medicine due to its diverse health functionalities.

NUTRIENTS (2021)

Article Biotechnology & Applied Microbiology

β-glucans: wide-spectrum immune-balancing food-supplement-based enteric (β-WIFE) vaccine adjuvant approach to COVID-19

Nobunao Ikewaki et al.

Summary: Conventional vaccines against COVID-19 are facing challenges due to the complexity of the virus and uncertainties about immunity duration. Using beta-glucans as an alternative treatment strategy could induce trained immunity and activate mucosal immunity, providing a potential solution until a widely available vaccine is developed.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)

Article Immunology

Parallels in Sepsis and COVID-19 Conditions: Implications for Managing Severe COVID-19

Charles Ochieng' Olwal et al.

Summary: Sepsis and COVID-19 share many pathophysiological and clinical features, both leading to consumptive thrombocytopenia, coagulopathy, multi-organ dysfunction syndrome, respiratory failure, among other complications. Therefore, lessons learned from sepsis care could potentially inform on COVID-19 management.

FRONTIERS IN IMMUNOLOGY (2021)

Article Biochemistry & Molecular Biology

Enhancement of β-Glucan Biological Activity Using a Modified Acid-Base Extraction Method from Saccharomyces cerevisiae

Enas Mahmoud Amer et al.

Summary: Beta-glucan extracted from Saccharomyces cerevisiae using a modified acid-base extraction method exhibited promising antimicrobial, immunomodulatory, and anti-cancer properties, showing potential for various applications in the future. Further research should focus on evaluating beta-glucan in different biological systems and elucidating the underlying mechanisms of action.

MOLECULES (2021)

Article Nutrition & Dietetics

Nutraceutical Screening in a Zebrafish Model of Muscular Dystrophy: Gingerol as a Possible Food Aid

Rosario Licitra et al.

Summary: Gingerol, a component of fresh ginger, showed potential as a dietary supplement for DMD patients due to its positive effects on locomotion and muscle structure phenotypes. While other compounds also showed partial positive effects, the nutraceutical screening study provided preliminary support only for the efficacy and safety of gingerol as a supplement for DMD.

NUTRIENTS (2021)

Review Critical Care Medicine

Interleukin-6 receptor blockade in patients with COVID-19: placing clinical trials into context

Federico Angriman et al.

Summary: The studies on IL-6 receptor antagonists show clinical and methodological heterogeneity, which may have led to apparently inconsistent results due to factors such as timing from clinical presentation to treatment, severity of illness, and concomitant use of corticosteroids.

LANCET RESPIRATORY MEDICINE (2021)

Article Cell Biology

Plasma IL-6 levels following corticosteroid therapy as an indicator of ICU length of stay in critically ill COVID-19 patients

Samir Awasthi et al.

Summary: Severe COVID-19 patients with high post-corticosteroid IL-6 levels had worse outcomes, suggesting a potential association between corticosteroid treatment and disease severity. The co-expression of NR3C1 and IL-6 in alveolar macrophages, smooth muscle cells, and endothelial cells indicates a possible link between NR3C1 function regulation and IL-6 levels in future studies.

CELL DEATH DISCOVERY (2021)

Editorial Material Immunology

Granulocyte-macrophage colony-stimulating factor: an immunotarget for sepsis and COVID-19

Xiuying Mu et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

Review Pharmacology & Pharmacy

Immune Intervention in Sepsis

Jian Chen et al.

Summary: Sepsis is a host immune disorder induced by infection, leading to multiple organ dysfunction syndrome with high morbidity and mortality. Despite significant progress in clinical diagnosis and treatment, there is still a lack of specific drugs for sepsis treatment.

FRONTIERS IN PHARMACOLOGY (2021)

Review Medicine, General & Internal

Immune Modulation in Critically Ill Septic Patients

Salvatore Lucio Cutuli et al.

Summary: Sepsis is a condition triggered by infection-induced immune alterations and can theoretically be improved through pharmacological or extracorporeal immune modulation therapies. While pharmacological immune modulation may have long-lasting effects, extracorporeal immune modulation allows for short-term removal of inflammatory mediators from the bloodstream. Despite the widespread use of these therapies in clinical practice, their specific role in critically ill septic patients remains unclear.

MEDICINA-LITHUANIA (2021)

Review Anesthesiology

Sepsis-induced Coagulopathy and Disseminated Intravascular Coagulation

Toshiaki Iba et al.

ANESTHESIOLOGY (2020)

Article Medicine, General & Internal

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China

Dawei Wang et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Review Pharmacology & Pharmacy

Immunotherapy in sepsis - brake or accelerate?

Folkert Steinhagen et al.

PHARMACOLOGY & THERAPEUTICS (2020)

Review Nutrition & Dietetics

Nutrition in Sepsis: A Bench-to-Bedside Review

Elisabeth De Waele et al.

NUTRIENTS (2020)

Review Respiratory System

An approach to antibiotic treatment in patients with sepsis

Maria Luisa Martinez et al.

JOURNAL OF THORACIC DISEASE (2020)

Article Oncology

Anti-infectious and Anti-tumor Activities of β-glucans

Vaclav Vetvicka et al.

ANTICANCER RESEARCH (2020)

Review Biochemistry & Molecular Biology

Use of Intravenous Immunoglobulins in Sepsis Therapy-A Clinical View

Dominik Jarczak et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Public, Environmental & Occupational Health

D-Dimer Concentrations and COVID-19 Severity: A Systematic Review and Meta-Analysis

Panagiotis Paliogiannis et al.

FRONTIERS IN PUBLIC HEALTH (2020)

Review Respiratory System

D-dimer levels and COVID-19 severity: Systematic Review and Meta-Analysis

Muhammed Emin Duz et al.

TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX (2020)

Article Immunology

GM-CSF-based treatments in COVID-19: reconciling opposing therapeutic approaches

Frederick M. Lang et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Review Critical Care Medicine

The gut microbiome's role in the development, maintenance, and outcomes of sepsis

Max W. Adelman et al.

CRITICAL CARE (2020)

Review Medicine, Research & Experimental

Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis

Sulmaz Ghahramani et al.

EUROPEAN JOURNAL OF MEDICAL RESEARCH (2020)

Letter Public, Environmental & Occupational Health

Ferritin levels and COVID-19

Manuel Vargas-Vargas et al.

REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH (2020)

Review Biochemistry & Molecular Biology

Beta Glucan: Supplement or Drug? From Laboratory to Clinical Trials

Vaclav Vetvicka et al.

MOLECULES (2019)

Article Biochemistry & Molecular Biology

Paramylon, a Potent Immunomodulator from WZSL Mutant of Euglena gracilis

Laura Barsanti et al.

MOLECULES (2019)

Editorial Material Biochemistry & Molecular Biology

AIMing Immunomodulation Therapy at Sepsis

Aleksandra Leligdowicz et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2019)

Review Infectious Diseases

Current gaps in sepsis immunology: new opportunities for translational research

Ignacio Rubio et al.

LANCET INFECTIOUS DISEASES (2019)

Review Critical Care Medicine

Corticosteroids in Sepsis: An Updated Systematic Review and Meta-Analysis

Bram Rochwerg et al.

CRITICAL CARE MEDICINE (2018)

Review Biochemistry & Molecular Biology

A critical review on the impacts of beta-glucans on gut microbiota and human health

Muthukumaran Jayachandran et al.

JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2018)

Article Medicine, Research & Experimental

Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial

Bruno Francois et al.

JCI INSIGHT (2018)

Review Medicine, General & Internal

Treatment of sepsis: What is the antibiotic choice in bacteremia due to carbapenem resistant Enterobacteriaceae?

Fatema Alhashem et al.

WORLD JOURNAL OF CLINICAL CASES (2017)

Review Immunology

Immunotherapeutic implications of IL-6 blockade for cytokine storm

Toshio Tanaka et al.

IMMUNOTHERAPY (2016)

Article Respiratory System

Metabolic resuscitation in sepsis: a necessary step beyond the hemodynamic?

Heitor Pons Leite et al.

JOURNAL OF THORACIC DISEASE (2016)

Review Nutrition & Dietetics

Immune-modulatory effects of dietary Yeast Beta-1,3/1,6-D-glucan

Heike Stier et al.

NUTRITION JOURNAL (2014)

Review Biochemistry & Molecular Biology

Special issue: Sepsis The new normal: immunomodulatory agents against sepsis immune suppression

Noe Ile A. Hutchins et al.

TRENDS IN MOLECULAR MEDICINE (2014)

Article Biochemistry & Molecular Biology

Comparison of the potency of a variety of β-glucans to induce cytokine production in human whole blood

Ilka Noss et al.

INNATE IMMUNITY (2013)

Article Medicine, General & Internal

Effect of Eritoran, an Antagonist of MD2-TLR4, on Mortality in Patients With Severe Sepsis The ACCESS Randomized Trial

Steven M. Opal et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)

Review Infectious Diseases

Immunomodulatory therapy for sepsis: an update

Eirini Christaki et al.

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2011)

Review Biochemistry & Molecular Biology

Serum ferritin: Past, present and future

Wei Wang et al.

BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2010)

Article Critical Care Medicine

Granulocyte-Macrophage Colony-stimulating Factor to Reverse Sepsis-associated Immunosuppression A Double-Blind, Randomized, Placebo-controlled Multicenter Trial

Christian Meisel et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)

Review Immunology

Clinical trials of immunomodulatory therapies in severe sepsis and septic shock

JL Vincent et al.

CLINICAL INFECTIOUS DISEASES (2002)